Dexcom (DXCM)

Dexcom (DXCM) Income Statement


Dexcom Income Statement

Last quarter (Q1 2023), Dexcom's total revenue was $741.50M, an increase of 17.92% from the same quarter last year. In Q1, Dexcom's net income was $48.60M. See Dexcom’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Revenue
$ 3.02B$ 2.91B$ 2.45B$ 1.93B$ 1.48B$ 1.03B
Cost of Revenue
$ 1.07B$ 1.03B$ 768.00M$ 646.60M$ 544.50M$ 367.70M
Gross Profit
$ 1.95B$ 1.88B$ 1.68B$ 1.28B$ 931.50M$ 663.90M
Operating Expense
$ 1.55B$ 1.49B$ 1.41B$ 980.60M$ 789.20M$ 850.20M
Operating Income
$ 397.10M$ 391.20M$ 265.80M$ 299.50M$ 142.30M$ -186.30M
Net Non Operating Interest Income Expense
$ -17.80M$ -18.60M$ -102.00M$ -68.60M$ -33.90M$ -20.30M
Other Income Expense
$ -3.90M$ -18.20M$ 10.10M$ -5.90M$ -4.20M$ 80.10M
Pretax Income
$ 419.20M$ 390.80M$ 173.90M$ 225.00M$ 104.20M$ -126.50M
Tax Provision
$ 126.70M$ 49.60M$ 19.20M$ -268.60M$ 3.10M$ 600.00K
Earnings From Equity Interest Net Of Tax
Net Income Common Stockholders
$ 292.50M$ 341.20M$ 154.70M$ 493.60M$ 101.10M$ -127.10M
Basic EPS
$ 0.76$ 0.88$ 0.40$ 1.31$ 1.11$ -1.44
Diluted EPS
$ 0.70$ 0.82$ 0.39$ 1.26$ 1.10$ -1.44
Basic Average Shares
$ 1.56B$ 389.40M$ 386.80M$ 377.60M$ 91.10M$ 88.20M
Diluted Average Shares
$ 1.69B$ 427.50M$ 400.40M$ 390.00M$ 92.30M$ 88.20M
Dividend Per Share
Total Operating Income As Reported
Reported Normalized Basic E P S
$ 0.34----$ 0.30
Reported Normalized Diluted E P S
$ 0.34-$ 0.67-$ 1.84$ 0.30
Rent Expense Supplemental
Total Expenses
$ 2.63B$ 2.52B$ 2.18B$ 1.63B$ 1.33B$ 1.22B
Net Income From Continuing And Discontinued Operation
$ 292.50M$ 341.20M$ 154.70M$ 493.60M$ 101.10M$ -127.10M
Normalized Income
$ 243.90M-$ 155.91M$ 497.91M$ 101.10M$ -127.10M
Interest Expense
$ 14.00M-$ 102.00M$ 84.70M$ 60.30M$ 22.70M
$ 437.80M$ 409.40M$ 275.90M$ 309.70M$ 164.50M$ -103.80M
$ 558.70M$ 416.90M$ 377.90M$ 376.80M$ 213.20M$ -74.70M
Currency in USD

Dexcom Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis